[
  {
    "ts": null,
    "headline": "Masimo Shares Dip Despite FDA Clears Expanded Use of O3 Monitoring",
    "summary": "MASI gains FDA clearance to expand O3 monitoring with delta hemoglobin parameters across all patient groups.",
    "url": "https://finnhub.io/api/news?id=7ad1f4a5fcda920d3dea814a9792dc30f7cc3fbb437663010e733fa9354c86b6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755710640,
      "headline": "Masimo Shares Dip Despite FDA Clears Expanded Use of O3 Monitoring",
      "id": 136450467,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "WST",
      "source": "Yahoo",
      "summary": "MASI gains FDA clearance to expand O3 monitoring with delta hemoglobin parameters across all patient groups.",
      "url": "https://finnhub.io/api/news?id=7ad1f4a5fcda920d3dea814a9792dc30f7cc3fbb437663010e733fa9354c86b6"
    }
  }
]